UK government commits to £8bn NHS boost
UK Chancellor George Osborne has committed to increasing NHS funding by £8 billion a year in the 2015 Budget.
Read MoreAuthor: George Underwood
US dominates at Creative Floor Awards
American companies dominated the Creative Floor Awards last Thursday, scooping 19 of the 31 prizes for creative work in healthcare.
Read MoreFDA approves new cystic fibrosis drug Orkambi
The FDA has approved Vertex Pharmaceuticals’ first-in-class cystic fibrosis (CF) treatment Orkambi.
Read MoreViiV set to offer cheap HIV drugs in China
ViiV Healthcare will offer cheap versions of its HIV drug Tivicay in China and other developing countries through a new partnership with Desano Pharmaceuticals.
Read MoreBoehringer COPD combination approved in Europe
Boehringer Ingelheim’s combination lung drug Spiolto has been approved in its first European countries, including the UK, for the treatment of chronic obstructive pulmonary disease (COPD) _
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
